[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LGND":3,"homepage-market-summary":31,"stock-news-LGND":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LGND","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Ligand Pharmaceuticals Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.","47","San Diego, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},306.77,303.95,309.77,300.7851,302.96,3.81,1.26,162766.27663,5878,306.43,326.63,175.89,251199.67280246216,86.8,8526,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},16,[176,182,188,194,200,206,212,217,223,229,234,240,246,250,256,261],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Ligand Pharmaceuticals (LGND) Stock May Be 27% Undervalued After A New Royalty Deal - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxPb05Sck1ZTE1RVVNEMnUwYVVLT2FzanpCQ2JZT0tQYjR1c3hURndLTWdXZk1VWk5jd0t0anVuXzBmNkQ5RnJlaUZGRXB1N2hPZEJHVUJHNWJRUVhOV1pjRG9rNVBoUkl5T1ZQb3RrM1ZnNlpHZlY0SVNwUkhVRG9DdlNZUUt5bkFMZE1reThGWkttdUtaR2N5LU5XeDBOcHB1NnRXXw?oc=5","Tue, 29 Sep 2026 10:05:03 GMT","Ligand Pharmaceuticals (LGND) Stock May Be 27% Undervalued After A New Royalty Deal Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPaEgyck9rUWYzOG8tSnd1aktJZzRCTnQ3LVN4N2hMdzNTSUpaSXk4Tk9rd01femR2VmpDZWZpWkhSTzdoLXJpQ0ROTjB4MXEwbWkwMHpoYVM0N3hSbzFvOUNPVk5SMS1ES1N1bkowRUc5ZFBpMkM5YVZCSDZaRWQ1ZWJLa3o0dVc0ZUcxeTdPOUxrMnJ1Y2RMcUFTOXBUQi1LWXhpQTQzRkdsX1A3ZGRKTVRqQmF0M0QwRy1keGN2V3Qzdw?oc=5","Sun, 04 Oct 2026 01:14:04 GMT","TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari Stocktwits","Stocktwits",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Ligand Pharmaceuticals (NASDAQ:LGND) Flashes Strong Trend and High-Growth Momentum Despite Setup Caution - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6AFBVV95cUxPbzVsRzF2LWdaajRFNXRQVzRhRWlmNV9JUWhfemVzR0I1S3Jua2U5UkFyR2VXdjRaMnpVMUtmOWYtRV96bUtMdHVNbkpFOVptcUJZWUgyeExLR3IyMEptbnpWVy0wTTNCQnRQUndqYXMzTWlpMy1uLTNpN1FTVFgyeTFybmlVUEVpQUpidVN5aUk0NFNualIxcWtoVlFEMl9Mb1VWVjBnanJ5cU1ldG5IRmwycmpnUE1CY0pHTVlHbUUyWlhKWWNBU002V1hkZDF1OE9wbnZIbXJhc05ZLTNGOUEyZW5iQ3VV?oc=5","Mon, 28 Sep 2026 11:20:59 GMT","Ligand Pharmaceuticals (NASDAQ:LGND) Flashes Strong Trend and High-Growth Momentum Despite Setup Caution ChartMill","ChartMill",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation (LGND:NASDAQ) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxPNEltUE8xUG9UeXlGUG1Id3FIUWVDNkdDMEtpb0xxYWFVX2t3WmNDZzFIZDBXRG1xdXUzVHc2RWpONDl3cTRpQjJkNHBPUmhUUW1iX1hXTlJ3RXl3S1R2QTdvbUM0Nkd0NXQyX3RqOTZhYXVRX29CcGNzQ1hIWE00RGZlSk5ZX2pnWWhXN2FWTE1Dc3lJOXpkY1U4bklFZUpNWUc2ekdnbzRXcnVoaHRpYjdZTQ?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation (LGND:NASDAQ) Seeking Alpha","Seeking Alpha",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Ryjunea Royalty Rights Deal - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 23 Sep 2026 18:49:37 GMT","How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Ryjunea Royalty Rights Deal Simply Wall Street","Simply Wall Street",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Liquidity Mapping Around (LGND) Price Events - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNMnVPTG1lYUZDUWlvQ1BhWXEzaFAtbXhQZ0czZ05zQ0ZLT1g4aWVuaHE5MTZ1YUg2b1VDdnpuWjhrdUxZRi1DYTNsbWt2M2dMWjFta2FSM3lwZzBRZ3U2VmdFWVBYaXVlN1dBUDNuM1dvWGM4N1pCTnNCRk53bXl6NkN2VHlZUVI1UC02aTlpTmhaSmN1SmdxY3Zqekl1MnJSQ2piejllY2F5QUVPM1g1NW5wZ3pLbFZSdnhiR0Q0NA?oc=5","Fri, 02 Oct 2026 17:10:01 GMT","Liquidity Mapping Around (LGND) Price Events Stock Traders Daily","Stock Traders Daily",{"title":213,"link":214,"pubDate":215,"description":216,"source":181},"Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxPOVBZTGZ1MnZCWXZlY090bXB4NWNfUHVEMnlieDZ5LW5qaDhJVFNCWnZKUGhZN2N3b2NTUnFfbER2czZ0UTRYc1JOaTdZWm1OMjlRcS1Cd1ZSamdSZkp2TmEtclBvQ2dwMDBjRU41VDA0M3ZaWlBPRm1kNmxpR2kxZ1VybkgxdDFuRjVYVTdycw?oc=5","Thu, 01 Oct 2026 11:46:24 GMT","Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts Yahoo Finance",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"Barclays Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $345 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxNREpndThBSkJfdGFvRnRXYkVLbWdVaDZSUngydFQtSHNEQUp5aDJDTEo0clJ3UEJ1LWVGYm4zdDhndzFkWFFXZ1prU3ZHdTN5MjRadzJRR1pWbm5tZlJnRmUwaHd4WC1iaFp4cHlTd3AxMWk1a0dMWHFtWng1M2FfaE9haXlhMHUySlVqZ1pFNWZVRWxXTHBSb1V6STBRTzcxTFlFM3hmX0dQM3dBY0IxaUZRU2Q0LV9SdENtcldwRWNkYjA?oc=5","Thu, 01 Oct 2026 05:29:48 GMT","Barclays Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $345 Moomoo","Moomoo",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"StoneX updates its best ideas list - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxQajZBT3dNWTIxU0pMRnRRd290N09Idl80emh2VG1pOVVFSHM3aGFxdUJkOGNLak9FU1pZOFJtU3JmRENoUmlMdFVreG1jcU5ySWhFc0tzN1draGg3Z2x1TnNral9ZS1RXcVpaUTFSc2stVzVyS2o2elgyV3RkczRoT1VUVDJ1NG0tc0hRRzl3b1psZVJMTVM2SzVlZ1Y1dw?oc=5","Thu, 01 Oct 2026 16:30:50 GMT","StoneX updates its best ideas list TradingView","TradingView",{"title":230,"link":231,"pubDate":232,"description":233,"source":205},"CAR T Funding Deal Could Be A Game Changer For Ligand Pharmaceuticals (LGND) - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 21:00:33 GMT","CAR T Funding Deal Could Be A Game Changer For Ligand Pharmaceuticals (LGND) Simply Wall Street",{"title":235,"link":236,"pubDate":237,"description":238,"source":239},"Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxNcFdkRmIyaDNnNEtyeEdsbkJKY0JhQkg5RnhaMEZKYS1GUEU4TnUzc2dla1c4a0d0UlFjQTU4YVUxTThZRk0tNzhBbEtFSi1lRlJiVkI2dDBScDJieXFzaVh5RFhCaHk4b2RfMzMzRVYzVGsxd0dkWVNtLVhxVkcyZ1VRaGRqWGstLXlxTkh3UDNlQS1fSTV3cFM4OVpDRndUSkY2UkJyZXZTUW10QW5JMEpGaDJ0TXJNYXRzRlU5a3BYeFlBbnc?oc=5","Thu, 24 Sep 2026 14:42:00 GMT","Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal By Investing.com Investing.com UK","Investing.com UK",{"title":241,"link":242,"pubDate":243,"description":244,"source":245},"Ligand Pharmaceuticals stock expands royalty pipeline with USD 47.00 million deal - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxQdUpieXFNNTV1S0Vza2lmM2IwOWtieFNfdDBXQVU5OFR2VkxXUEZUcUFYVlVET0pHdWF0QnVWaUc2QmFMSHdCSDYtRE9zQWNkUmN6N3FDMG9hNjN6RHlnbnM0ZF9DcTRXdjZTd1BlR2ZfNW11MlRWUjZGWFdvY05meWdiMmtxN2RuMDJtUGw4QzYxQkljOEpRYW95OE96NHA5bjJSYV9xanBnbTFnY0xlaGlJc1F3ZWl5cmFFYl9sS1lfVDNtYmc?oc=5","Wed, 30 Sep 2026 22:50:21 GMT","Ligand Pharmaceuticals stock expands royalty pipeline with USD 47.00 million deal AD HOC NEWS","AD HOC NEWS",{"title":247,"link":248,"pubDate":197,"description":249,"source":181},"Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxNOGoxNF9ZMmhJSHU2SF9VS2dnejFnQ3BxQWNxZHZBVmlNYUVUdWp4REN6SWpYd1hKeldybXRSd0F0TmVKRGhRUHk3Vnktc3Fwd2NlSHUyR0o0THBHWFRnS3ZFRkJEcVJ0ZF9qVFh4bmV2b3R6RlVLNHViQWFNcHZVYlZNMU10cXhuQU40STVxRGRTVElXZTlxdEpyQ3NmendOTE9LdFh1TTJ1dGtENko4Z0JEZ0E1aXk2?oc=5","Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target Yahoo Finance",{"title":251,"link":252,"pubDate":253,"description":254,"source":255},"Ligand Pharmaceuticals (LGND) Faces A Valuation Test After Expanding Ryjunea Royalties - Simply Wall St","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 24 Sep 2026 23:54:04 GMT","Ligand Pharmaceuticals (LGND) Faces A Valuation Test After Expanding Ryjunea Royalties Simply Wall St","Simply Wall St",{"title":257,"link":258,"pubDate":259,"description":260,"source":245},"Ligand Pharmaceuticals stock reports stronger royalty growth after Q2 results - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxQX291dHhZWnM1S1hLVkZmSFRjNnBnQWJJY19tNHJxR3hfQVd6S1BoN09xbzZickczQ2stVW56R2wtMkVUeEM1RFJOZWEyMjR1X25sY184UTBNRF9XM0w0QmkzSm5EWU9IVVotM01xWF9HVTBJMmJoYVh1NTdTWTdWT2xFZDZaZnBLS3d0NUZRUWtia2dlcHZVVkhQWkk1aEF4aUZ1dUlYQXp4NlJNYmthbEtwRjZtOHUxM0VieS1RN09sMG5MWlhhb0V3V3FrOW1lOXdWM3hxcw?oc=5","Sun, 04 Oct 2026 18:01:11 GMT","Ligand Pharmaceuticals stock reports stronger royalty growth after Q2 results AD HOC NEWS",{"title":262,"link":263,"pubDate":264,"description":265,"source":266},"LGND Dec 2027 260.000 call (LGND271217C00260000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE1mdWFfRVRWbTNlQVdrZGg0SDR1Rk5jbXU5OUt5Qlh5X3F0Zk9faFZJUUd6cGdfLUdGSHY2Yy16WnFyMTRuN29GU3BaNlowZ2ZuUGFZWTBsSFJ6a0V5YlJ5QVczNl9DbDJSTlptc2Rn?oc=5","Fri, 02 Oct 2026 16:30:55 GMT","LGND Dec 2027 260.000 call (LGND271217C00260000) Interactive Stock Chart Yahoo! Finance Canada","Yahoo! Finance Canada"]